Health Condition 1: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: Formoterol fluticasone propionate fixed dose combination in adult asthma patients: Formoterol 6 mcg and fluticasone propionate 250 mcg administered twice daily inhalation in adult asth
Sponsors
Department of Chest and Tb Sri Guru Ramdas University of health sciences amritsar
Eligibility
Inclusion criteria
Inclusion criteria: Adults greater than 18 years with the diagnosis of asthma as per GINA guidelines will be included in this study
Exclusion criteria
Exclusion criteria: Patients with unstable angina heart failure recent acute MI within 4 to 6 weeks suspected presence of active TB and other communicable respiratory diseases patients with respiratory failure patients with neurological musculoskeletal and peripheral vascular diseases patients with pneumonia and other respiratory illnesses limiting patients chest movements abdominal or thoracic aortic aneurysm active hemoptysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the clinical effect of Formoterol and fluticasone propionate versus vilanterol and fluticasone furoate fixed dose combination in adult asthma patients it aims to evaluate their impact on symptom control lung functionTimepoint: At baseline at 2 weeks then at 4 weeks and then at 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr B C Sarin
Sri Guru Ramdas University of health sciences
Outcome results
None listed